Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39314

DNAJC5 Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

The DNAJC5 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of the EGFR-mutant NCI-H1975 lung adenocarcinoma line, lacking cysteine string protein ?? (CSP??) expression. CSP??, a J-domain co-chaperone, partners with Hsp70 to maintain SNARE complex integrity via SNAP25 and syntaxin-1. Knockout of DNAJC5 disrupts protein folding and vesicle trafficking, making this model ideal for investigating co-chaperone functions in cancer proteostasis, stress signaling (JNK pathway), and EGFR TKI resistance. Applications include western blotting, co-immunoprecipitation, and drug sensitivity assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    DNAJC5

    Gene Identifier

    NCBI Gene ID 80331

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC5 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the NCI-H1975 human lung adenocarcinoma cell line, harboring a targeted disruption of the DNAJC5 gene. This loss-of-function model abolishes expression of cysteine string protein alpha (CSP??), a synaptic vesicle co-chaperone, enabling in-depth investigation of CSP??-mediated protein homeostasis and trafficking processes in a cancer-relevant epithelial background.

NCI-H1975 is a widely employed non-small cell lung cancer (NSCLC) cell line established from a female patient and characterized by the presence of EGFR L858R and T790M activating and resistance mutations. It serves as a key model for studying EGFR tyrosine kinase inhibitor (TKI) resistance and epithelial signaling biology, endowing the DNAJC5 knockout variant with a clinically relevant mutation context for dissecting chaperone?Concogene interplay.

CSP??, encoded by DNAJC5, functions as a J-domain co-chaperone that recruits Hsp70/HSPA8 chaperones to client proteins, particularly the SNARE complex components SNAP25 and syntaxin-1, to facilitate proper protein folding and prevent aggregation. CSP?? also interacts with synaptotagmin, 14-3-3 proteins, and Hsc70, and is regulated by HSF1 under heat shock and ER stress conditions, as well as by palmitoylation-dependent membrane anchoring. Downstream, CSP?? supports SNARE complex stability and neurotransmitter release; ablation of DNAJC5 disrupts Hsp70-dependent chaperone activity, leading to impaired SNARE-mediated membrane fusion, accumulation of misfolded proteins, and aberrant activation of the JNK stress kinase pathway.

In the NCI-H1975 background, loss of CSP?? introduces chronic proteotoxic stress and altered vesicle trafficking, which may intersect with EGFR-driven survival signaling and TKI resistance mechanisms. The JNK pathway, which is influenced by CSP??, is known to modulate apoptosis and cell migration downstream of EGFR, positioning this knockout model as a unique tool to dissect how co-chaperone dysfunction impacts lung adenocarcinoma cell fitness, stress adaptation, and drug sensitivity.

Researchers can employ this polyclonal knockout population to study the role of CSP?? in non-neuronal contexts, investigate chaperone-mediated regulation of SNARE proteins in cancer, and explore how proteostasis perturbation influences EGFR TKI response. Representative assays include western blotting for CSP?? and SNAP25, RT-qPCR for DNAJC5, co-immunoprecipitation with Hsp70, apoptosis and migration/invasion analyses, phospho-JNK profiling, and EGFR inhibitor sensitivity testing. For additional details or technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)